Product
1% Methotrexate
1 clinical trial
1 indication
Indication
Non-segmental VitiligoClinical trial
The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients With Active VitiligoStatus: Completed, Estimated PCD: 2023-06-01